Cargando…

Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients

BACKGROUND: Cholangiocarcinoma (CCA) is an aggressive disease with poor prognosis. A molecular classification based on mutational, methylation and transcriptomic features could allow identifying tailored therapies to improve CCA patient outcome. Proteomic remains partially unexplored; here, we analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalloni, Giuliana, Peraldo-Neia, Caterina, Massa, Annamaria, Bergamini, Carlo, Trentini, Alessandro, De Rosa, Giovanni, Daniele, Lorenzo, Ciccosanti, Fabiola, Cervellati, Carlo, Leone, Francesco, Aglietta, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317365/
https://www.ncbi.nlm.nih.gov/pubmed/34320944
http://dx.doi.org/10.1186/s12885-021-08576-z
_version_ 1783730056272543744
author Cavalloni, Giuliana
Peraldo-Neia, Caterina
Massa, Annamaria
Bergamini, Carlo
Trentini, Alessandro
De Rosa, Giovanni
Daniele, Lorenzo
Ciccosanti, Fabiola
Cervellati, Carlo
Leone, Francesco
Aglietta, Massimo
author_facet Cavalloni, Giuliana
Peraldo-Neia, Caterina
Massa, Annamaria
Bergamini, Carlo
Trentini, Alessandro
De Rosa, Giovanni
Daniele, Lorenzo
Ciccosanti, Fabiola
Cervellati, Carlo
Leone, Francesco
Aglietta, Massimo
author_sort Cavalloni, Giuliana
collection PubMed
description BACKGROUND: Cholangiocarcinoma (CCA) is an aggressive disease with poor prognosis. A molecular classification based on mutational, methylation and transcriptomic features could allow identifying tailored therapies to improve CCA patient outcome. Proteomic remains partially unexplored; here, we analyzed the proteomic profile of five intrahepatic cholangiocarcinoma (ICC) derived from Italian patients undergone surgery and one normal bile duct cell line. METHODS: Proteome profile was investigated by using 2D electrophoresis followed by Mass Spectrometry (MS). To validate proteomic data, the expression of four overexpressed proteins (CAT, SOD, PRDX6, DBI/ACBP) was evaluated by immunohistochemistry in an independent cohort of formalin fixed, paraffin-embedded (FFPE) ICC tissues. We also compared proteomic data with those obtained by transcriptomic profile evaluated by microarray analysis of the same tissues. RESULTS: We identified 19 differentially expressed protein spots, which were further characterized by MS; 13 of them were up- and 6 were down-regulated in ICC. These proteins are mainly involved in redox processes (CAT, SODM, PRDX2, PRDX6), in metabolism (ACBP, ACY1, UCRI, FTCD, HCMS2), and cell structure and organization (TUB2, ACTB). CAT is overexpressed in 86% of patients, PRDX6 in 73%, SODM in 100%, and DBI/ACBP in 81% compared to normal adjacent tissues. A concordance of 50% between proteomic and transcriptomic data was observed. CONCLUSIONS: This study pointed out that the impairment of the metabolic and antioxidant systems, with a subsequent accumulation of free radicals, might be a key step in CCA development and progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08576-z.
format Online
Article
Text
id pubmed-8317365
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83173652021-07-28 Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients Cavalloni, Giuliana Peraldo-Neia, Caterina Massa, Annamaria Bergamini, Carlo Trentini, Alessandro De Rosa, Giovanni Daniele, Lorenzo Ciccosanti, Fabiola Cervellati, Carlo Leone, Francesco Aglietta, Massimo BMC Cancer Research BACKGROUND: Cholangiocarcinoma (CCA) is an aggressive disease with poor prognosis. A molecular classification based on mutational, methylation and transcriptomic features could allow identifying tailored therapies to improve CCA patient outcome. Proteomic remains partially unexplored; here, we analyzed the proteomic profile of five intrahepatic cholangiocarcinoma (ICC) derived from Italian patients undergone surgery and one normal bile duct cell line. METHODS: Proteome profile was investigated by using 2D electrophoresis followed by Mass Spectrometry (MS). To validate proteomic data, the expression of four overexpressed proteins (CAT, SOD, PRDX6, DBI/ACBP) was evaluated by immunohistochemistry in an independent cohort of formalin fixed, paraffin-embedded (FFPE) ICC tissues. We also compared proteomic data with those obtained by transcriptomic profile evaluated by microarray analysis of the same tissues. RESULTS: We identified 19 differentially expressed protein spots, which were further characterized by MS; 13 of them were up- and 6 were down-regulated in ICC. These proteins are mainly involved in redox processes (CAT, SODM, PRDX2, PRDX6), in metabolism (ACBP, ACY1, UCRI, FTCD, HCMS2), and cell structure and organization (TUB2, ACTB). CAT is overexpressed in 86% of patients, PRDX6 in 73%, SODM in 100%, and DBI/ACBP in 81% compared to normal adjacent tissues. A concordance of 50% between proteomic and transcriptomic data was observed. CONCLUSIONS: This study pointed out that the impairment of the metabolic and antioxidant systems, with a subsequent accumulation of free radicals, might be a key step in CCA development and progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08576-z. BioMed Central 2021-07-28 /pmc/articles/PMC8317365/ /pubmed/34320944 http://dx.doi.org/10.1186/s12885-021-08576-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Cavalloni, Giuliana
Peraldo-Neia, Caterina
Massa, Annamaria
Bergamini, Carlo
Trentini, Alessandro
De Rosa, Giovanni
Daniele, Lorenzo
Ciccosanti, Fabiola
Cervellati, Carlo
Leone, Francesco
Aglietta, Massimo
Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
title Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
title_full Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
title_fullStr Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
title_full_unstemmed Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
title_short Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
title_sort proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in italian intrahepatic cholangiocarcinoma patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317365/
https://www.ncbi.nlm.nih.gov/pubmed/34320944
http://dx.doi.org/10.1186/s12885-021-08576-z
work_keys_str_mv AT cavallonigiuliana proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT peraldoneiacaterina proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT massaannamaria proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT bergaminicarlo proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT trentinialessandro proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT derosagiovanni proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT danielelorenzo proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT ciccosantifabiola proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT cervellaticarlo proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT leonefrancesco proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients
AT agliettamassimo proteomicanalysisidentifiesderegulatedmetabolicandoxidativeassociatedproteinsinitalianintrahepaticcholangiocarcinomapatients